Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Interest & Investment Income (2016 - 2025)

OptimizeRx's Interest & Investment Income history spans 13 years, with the latest figure at $91000.0 for Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 14.95% year-over-year to $91000.0; the TTM value through Sep 2025 reached $367000.0, up 4.56%, while the annual FY2024 figure was $329000.0, 84.99% down from the prior year.
  • Interest & Investment Income for Q3 2025 was $91000.0 at OptimizeRx, up from $90000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $721000.0 in Q2 2023 and bottomed at $931.0 in Q1 2021.
  • The 4-year median for Interest & Investment Income is $91000.0 (2025), against an average of $187265.3.
  • The largest annual shift saw Interest & Investment Income tumbled 98.32% in 2021 before it soared 340.0% in 2025.
  • A 4-year view of Interest & Investment Income shows it stood at $2383.0 in 2021, then skyrocketed by 4851.74% to $118000.0 in 2023, then dropped by 16.95% to $98000.0 in 2024, then fell by 7.14% to $91000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Interest & Investment Income are $91000.0 (Q3 2025), $90000.0 (Q2 2025), and $88000.0 (Q1 2025).